EV-014-3001

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameEV-014-3001

Drug Alias Nameanticancer agents (Evolva Biotech)EV-014-3001

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEvolva Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEvolva Sa

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A